Melissa A. Bradley, Ph.D. - Publications
Affiliations: | 2012 | University of Kentucky, Lexington, KY |
Area:
Biochemistry, Analytical ChemistryYear | Citation | Score | |||
---|---|---|---|---|---|
2012 | Lovell MA, Bradley MA, Fister SX. 4-Hydroxyhexenal (HHE) impairs glutamate transport in astrocyte cultures. Journal of Alzheimer's Disease : Jad. 32: 139-46. PMID 22766736 DOI: 10.3233/Jad-2012-120409 | 0.512 | |||
2012 | Bradley MA, Xiong-Fister S, Markesbery WR, Lovell MA. Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression. Neurobiology of Aging. 33: 1034-44. PMID 20965613 DOI: 10.1016/J.Neurobiolaging.2010.08.016 | 0.569 | |||
2011 | Weidner AM, Bradley MA, Beckett TL, Niedowicz DM, Dowling AL, Matveev SV, LeVine H, Lovell MA, Murphy MP. RNA oxidation adducts 8-OHG and 8-OHA change with Aβ42 levels in late-stage Alzheimer's disease. Plos One. 6: e24930. PMID 21949792 DOI: 10.1371/Journal.Pone.0024930 | 0.54 | |||
2011 | Lovell MA, Soman S, Bradley MA. Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain. Mechanisms of Ageing and Development. 132: 443-8. PMID 21878349 DOI: 10.1016/J.Mad.2011.08.003 | 0.579 | |||
2011 | Timmons MD, Bradley MA, Lovell MA, Lynn BC. Procedure for the isolation of mitochondria, cytosolic and nuclear material from a single piece of neurological tissue for high-throughput mass spectral analysis. Journal of Neuroscience Methods. 197: 279-82. PMID 21392528 DOI: 10.1016/J.Jneumeth.2011.02.027 | 0.414 | |||
2010 | Bradley MA, Markesbery WR, Lovell MA. Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radical Biology & Medicine. 48: 1570-6. PMID 20171275 DOI: 10.1016/J.Freeradbiomed.2010.02.016 | 0.544 | |||
Show low-probability matches. |